Postprandial lipoprotein metabolism: VLDL vs chylomicronsKatsuyuki Nakajima, Akira Tanaka, Takamitsu Nakano et al.|Clinica Chimica Acta|2011Cited by 173
Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of JapanHiroshi Mabuchi, Junji Koizumi, Atsushi Nohara et al.|Atherosclerosis|2010Cited by 121
Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic PatientsHiroshi Mabuchi, Junji Kobayashi, Toshinori Higashikata et al.|Journal of Atherosclerosis and Thrombosis|2005Cited by 118
Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: A randomized double-blind studyHiroshi Mabuchi, Junji Koizumi, Atsushi Nohara et al.|Atherosclerosis|2007Cited by 100
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutationHiroshi Mabuchi, Junji Koizumi, Atsushi Nohara et al.|Atherosclerosis|2014Cited by 87